- Home
- » Tags
- » Acorda Therapeutics
Top View
- A Company Aligned. a Mission Defined
- Manufacturers and Wholesalers Street City ST Zip Acorda Therapeutics
- 05/09/2016 Provider Subsystem Healthcare and Family Services Run Time: 04:25:50 Report Id 2794D051 Page: 01
- 2020 Marketing Code of Conduct Compliant Companies
- Acorda to Pay $525M for Boston Biopharma Company
- Proxy Statement and Annual Report and Authorize a Proxy to Vote Your Shares Online
- Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
- IEIH Ishares Evolved US Innovative Healthcare ETF Gray Swan Event
- Medicaid System (Mmis) Illinois Department of Run Date: 11/09/2016 Provider Subsystem Healthcare and Family Services Run Time: 20:25:21 Report Id 2794D052 Page: 01
- MED-Project Participating Drug Companies - King County Washington, March 2020
- Portfolio Index List V26.Xlsx
- 02/10/2015 Provider Subsystem Healthcare and Family Services Run Time: 20:51:09 Report Id 2794D051 Page: 01
- By Forging New Relationships and Finding Novel
- ACORDA THERAPEUTICS, INC. 420 Saw Mill River Road, Ardsley, New York 10502
- ACORDA THERAPEUTICS INC. V. MYLAN PHARM
- Biogen Idec's Agenda
- Third Quarter Report
- Active Labelers Run Date : Aug 26, 2021
- Manufacturers and Wholesalers Street City ST Zip Submitted Under
- Gerald J. Flattmann, Jr
- In the United States District Court for the District of Delaware
- Scrappy but Savvy Acorda’S Lawyers Do a Bit of Everything—And Like It That Way
- 0620-328 IC20 Faculty Export2.Xlsx
- A Declaration from Members of the World's Biotechnology Sector On
- 20200915 MED-Project Participant List.Xlsx
- DICERNA PHARMACEUTICALS, INC. (Exact Name of Registrant As Specified in Its Charter)
- A 12-Month, Dose-Level Blinded Safety and Efficacy Study of Levodopa Inhalation Powder (CVT-301, Inbrija) in Patients with Parkinson's Disease
- In the United States District Court for the District of Delaware
- Theravance Biopharma Appoints Andrew Hindman As Senior Vice President and Chief Financial Officer
- Biogen Idec Inc. (Exact Name of Registrant As Specified in Its Charter)
- Current Sustaining Member Companies
- Q4 and Full Year 2020 Biogen Earnings Presentation
- P53465 Acorda Therapeutics, Inc. Nps 2021 V3
- Rebateable Manufacturers
- ACORDA THERAPEUTICS, INC. 420 Saw Mill River Road, Ardsley, New York 10502
- United States Securities and Exchange Commission Washington, D.C
- Manufacturer's W/Start/End Dates and Sc Ind Appendix 1
- Deal Point Data Rankings Include Mergers & Acquisitions With
- Disclosure Index - Sessions
- Acorda Therapeutics Inc
- P Number Manufacturer Name P1001 Forest Laboratories, Inc. P1002
- 05/13/2021 Provider Subsystem Healthcare and Family Services Run Time: 20:39:26 Report Id 2794D052 Page: 01
- Brief Amicus Curiae of Intellectual Property Owners